{"title": "PDF", "author": "PDF", "url": "https://training.cochrane.org/sites/training.cochrane.org/files/public/uploads/Epistemonikos%20equity%20filter.pdf", "hostname": "PDF", "description": "PDF", "sitename": "PDF", "date": "PDF", "cleaned_text": "Gabriel Rada (@radagabriel) radagabriel@epistemonikos.org Fundaci\u00f3n Epistemonikos (@epistemonikos) Santiago, Chile A day with... Equity Methods Group - Mapping health equity: Epistemonikos equity lter Plan for today Brief introduction to Epistemonikos Living OVerview of Evidence (L\u00b7OVE) classication platform Equity lter - taxonomy, strategies, algorithms and data reuse Challenges and opportunities A classication platform Connected with tools and projects L\u00b7OVE COVID-19: a proof of concept A repository Systematic methods https://app.iloveevidence.com/covid19/methods Over 550,000 records All type of articles The largest COVID-19 repository A repository 1 2 3 Launched in June 2020 iloveevidence.com A repository 1 2 3 Launched in June 2020 iloveevidence.com Pubmed/medline EMBASE CINAHL PsycINFO LILACS Wanfang Database Chinese Biomedical Literature Database Chinese National Knowledge Infrastructure Chinese Scientic Journal Database IRIS IRIS PAHO \u00cdndice Bibliogr\u00e1co de la Salud Microsoft Academic LensOther sources: Studies included in reviews Relevant COVID-19 websites Press release websites Twitter searches Articles sent by users ICTRP Search Portal Clinicaltrials.gov ISRCTN registry Chinese Clinical Trial Registry IRCT - Iranian Registry of Clinical Trials EU Clinical Trials Register: Clinical trials for covid-19 NIPH Clinical Trials Search Japan Primary Registries Network UMIN-CTR - UMIN Clinical Trials Registry JRCT - Japan Registry of Clinical Trials JAPIC Clinical Trials Information Clinical Research Information Service (CRiS), ANZCTR - Australian New Zealand Clinical Trials ReBec - Brazilian Clinical Trials Registry CTRI - Clinical Trials Registry - India RPCEC - Cuban Public Registry of Clinical Trials DRKS - German Clinical Trials Register LBCTR - Lebanese Clinical Trials Registry TCTR - Thai Clinical Trials Registry NTR - The Netherlands National Trial Register PACTR - Pan African Clinical Trial Registry REPEC - Peruvian Clinical Trial Registry SLCTR - Sri Lanka Trials Registry medRxiv bioRxiv SSRN Preprints ChinaXiv SciELO Preprints Research Square A repository 1 2 3 Total number of articles in the COVID-19 L\u00b7OVE repository A repository 1 2 3 https://app.iloveevidence.com/covid19/methods Alternatives to a formal repository A repository similar to COVID-19 can be built in days. Uploading a le with references (e.g. RIS) Connecting another database with L\u00b7OVE classication platform also possible. Classication platform Taxonomy Boolean strategies Algorithm/classiers (Articial intelligence and other technologies (classiers) Screening tool (human) data reuse A classication platform 1 2 3 Owned taxonomy to map 'all possible reviews questions': >5,000 terms, covering PICO elements, type of article, research designs and contextual factors The platform automatically combines the boolean strategies and classiers for all the terms and sets the screening tool L\u00b7OVE map Term 1 Term 2 A classication platform 1 2 3 A classication platform 1 2 3 COVID-19 MaskingA classication platform 1 2 3 COVID-19 Masking Equity lter (((vaccin* OR immunization OR immunogenic \"sars-cov2\" OR \"2019-ncov\" OR (wuhan* AND (virus OR viruses OR viral)) OR (covid* AND (virus OR viruses OR viral)) OR \"covid-19-related\" OR \"SARS-CoV-2-related\" OR \"SARS-CoV2-related\" OR \"2019-nCoV-related\" AND ((sars* OR covid*) AND vaccine))) OR (DelNS1* OR ((Influenza OR flu OR \"flu-based\") AND vector AND vaccine AND (COVID* OR SARS*))) OR (V591* OR \"V-591\" OR ((Merck OR MSD) AND (covid* OR SARS*) AND vaccine)) OR (V590* OR \"V-590\" OR ((Merck OR MSD) AND (covid* OR AND OR \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR antisars* OR \"anti-sars-cov-2\" OR \"anti-sars-cov2\" OR ((Oxford* AND OR Bio\") vaccin*) OR Covishield* OR Vaxzevria*) OR (covishield* ((Serum AND Institute AND India) AND vaccin*)) OR (\"Gam-COVID-Vac\" OR \"Gam COVID Vac\" OR ZIFIVAX* ) OR (EpiVacCorona* OR (EpiVac AND OR SARS*)) OR \"mvc-cov1901\" OR mvccov1901*) OR ((sinopharm* AND OR OR CDX005*) OR ((calculator* OR algorithm* OR scale OR score OR scoring OR prediction* OR rule* ((predict* OR progno* OR decision*) AND model) (risk stratificat*)) AND (COVID* OR sars* OR post-covid*)) n-cov* OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR *cv-19* OR sars* OR sari OR \"severe acute respiratory \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" severity exacerbat* mild severe* severity* OR moderate* \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" ((subtype* OR polymorphism* OR mutant* OR variant* OR OR \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" OR (alpha AND OR OR (((variant OR VOC) AND (\"south africa\" OR southafrica* OR Nelson OR Mandela)) OR \"B.1.351\" OR B1351* OR 20H* OR 20C* OR 501Y* B1429* \"CAL.20C\" CAL20C*) (((variant OR VOC) AND (brazilian* OR Manaus* OR Amazon*)) OR \"P.1\" OR (gamma AND OR \"sars-cov2\" OR \"2019-ncov\" OR (wuhan* AND (virus OR viruses OR viral)) OR (covid* AND (virus OR viruses OR viral)) OR \"covid-19-related\" OR \"SARS-CoV-2-related\" OR \"SARS-CoV2-related\" OR \"2019-nCoV-related\" AND ((sars* OR covid*) AND vaccine))) OR (DelNS1* OR ((Influenza OR flu OR \"flu-based\") AND vector AND vaccine AND (COVID* OR SARS*))) OR (V591* OR \"V-591\" OR ((Merck OR MSD) AND (covid* OR SARS*) AND vaccine)) OR (V590* OR \"V-590\" OR ((Merck OR MSD) AND (covid* OR AND OR \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR antisars* OR \"anti-sars-cov-2\" OR \"anti-sars-cov2\" OR ((Oxford* AND OR Bio\") vaccin*) OR Covishield* OR Vaxzevria*) OR (covishield* ((Serum AND Institute AND India) AND vaccin*)) OR (\"Gam-COVID-Vac\" OR \"Gam COVID Vac\" OR ZIFIVAX* ) OR (EpiVacCorona* OR (EpiVac AND OR SARS*)) OR \"mvc-cov1901\" OR mvccov1901*) OR ((sinopharm* AND OR OR CDX005*) OR ((calculator* OR algorithm* OR scale OR score OR scoring OR prediction* OR rule* ((predict* OR progno* OR decision*) AND model) (risk stratificat*)) AND (COVID* OR sars* OR post-covid*)) n-cov* OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR *cv-19* OR sars* OR sari OR \"severe acute respiratory \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" severity exacerbat* mild severe* severity* OR moderate* \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" ((subtype* OR polymorphism* OR mutant* OR variant* OR OR \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" OR (alpha AND OR OR (((variant OR VOC) AND (\"south africa\" OR southafrica* OR Nelson OR Mandela)) OR \"B.1.351\" OR B1351* OR 20H* OR 20C* OR 501Y* B1429* \"CAL.20C\" CAL20C*) (((variant OR VOC) AND (brazilian* OR Manaus* OR Amazon*)) OR \"P.1\" OR (gamma AND OR \"sars-cov2\" OR \"2019-ncov\" OR (wuhan* AND (virus OR viruses OR viral)) OR (covid* AND (virus OR viruses OR viral)) OR \"covid-19-related\" OR \"SARS-CoV-2-related\" OR \"SARS-CoV2-related\" OR \"2019-nCoV-related\" 024414\" \"CX024414\") (EpiVacCorona* \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR antisars* OR \"anti-sars-cov-2\" OR \"anti-sars-cov2\" OR \"anti-sarscov-2\" ((Oxford* AND OR Bio\") \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" ZIFIVAX* ) OR (((FINLAY* AND (covid* OR sars* OR \"sars-cov2\" OR \"2019-ncov\" OR (wuhan* AND (virus OR viruses OR viral)) OR (covid* AND (virus OR viruses OR viral)) OR \"covid-19-related\" OR \"SARS-CoV-2-related\" OR \"SARS-CoV2-related\" OR \"2019-nCoV-related\" OR \"cv-19-related\" n-cov* OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR *cv-19* OR sars* OR sari OR \"severe acute respiratory inequalit* OR disparit* OR marginali* OR minority OR minorities)) AND ((((intubation* OR enclosure* OR aerosol* OR barrier*) AND (box OR (intubat* AND shield*)) OR ((protective* AND equipment*) OR dickersons* OR gumshoes* OR rubbers*) OR (mask OR masks) OR (facemask* OR OR OR Technologies for of article ( Deep neural network: XLNet) Machine learning or other technologies for each term of the taxonomy More than 1 classier per term (humans solve discrepancies) A classication platform 1 2 3 Sensitivity COVID-19 93-100% Type of article COVID-19? 94-97% Equity and sub-terms Probably varies for different components: in process A classication platform 1 2 3 A classication platform 1 2 3 COVID-19 Masking LMICWhat's in a term E.g. LMIC A classication platform 1 2 3 (((vaccin* OR immunization OR immunogenic OR immunisation OR \"sars-cov2\" OR \"2019-ncov\" OR (wuhan* AND (virus OR viruses OR viral)) OR (covid* AND (virus OR viruses OR viral)) OR \"covid-19-related\" OR \"SARS-CoV-2-related\" OR \"SARS-CoV2-related\" OR \"2019-nCoV-related\" AND ((sars* OR covid*) AND vaccine))) OR (DelNS1* OR ((Influenza OR flu OR \"flu-based\") AND vector AND vaccine AND (COVID* OR SARS*))) OR (V591* OR \"V-591\" OR ((Merck OR MSD) AND (covid* OR SARS*) AND vaccine)) OR (V590* OR \"V-590\" OR ((Merck OR MSD) AND (covid* OR AND OR \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR antisars* OR \"anti-sars-cov-2\" OR \"anti-sars-cov2\" OR ((Oxford* AND OR Bio\") vaccin*) OR Covishield* OR Vaxzevria*) OR (covishield* ((Serum AND Institute AND India) AND vaccin*)) OR (\"Gam-COVID-Vac\" OR \"Gam COVID Vac\" OR ZIFIVAX* ) OR (EpiVacCorona* OR (EpiVac AND OR SARS*)) OR \"mvc-cov1901\" OR mvccov1901*) OR ((sinopharm* AND OR OR CDX005*) OR ((calculator* OR algorithm* OR scale OR score OR scoring OR prediction* OR rule* ((predict* OR progno* OR decision*) AND model) (risk stratificat*)) AND (COVID* OR sars* OR post-covid*)) n-cov* OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR *cv-19* OR sars* OR sari OR \"severe acute respiratory \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" severity exacerbat* mild severe* severity* OR moderate* \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" ((subtype* OR polymorphism* OR mutant* OR variant* OR OR \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" OR (alpha AND OR OR (((variant OR VOC) AND (\"south africa\" OR southafrica* OR Nelson OR Mandela)) OR \"B.1.351\" OR B1351* OR 20H* OR 20C* OR 501Y* B1429* \"CAL.20C\" CAL20C*) (((variant OR VOC) AND (brazilian* OR Manaus* OR Amazon*)) OR \"P.1\" OR (gamma AND OR \"sars-cov2\" OR \"2019-ncov\" OR (wuhan* AND (virus OR viruses OR viral)) OR (covid* AND (virus OR viruses OR viral)) OR \"covid-19-related\" OR \"SARS-CoV-2-related\" OR \"SARS-CoV2-related\" OR \"2019-nCoV-related\" AND ((sars* OR covid*) AND vaccine))) OR (DelNS1* OR ((Influenza OR flu OR \"flu-based\") AND vector AND vaccine AND (COVID* OR SARS*))) OR (V591* OR \"V-591\" OR ((Merck OR MSD) AND (covid* OR SARS*) AND vaccine)) OR (V590* OR \"V-590\" OR ((Merck OR MSD) AND (covid* OR AND OR \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR antisars* OR \"anti-sars-cov-2\" OR \"anti-sars-cov2\" OR ((Oxford* AND OR Bio\") vaccin*) OR Covishield* OR Vaxzevria*) OR (covishield* ((Serum AND Institute AND India) AND vaccin*)) OR (\"Gam-COVID-Vac\" OR \"Gam COVID Vac\" OR ZIFIVAX* ) OR (EpiVacCorona* OR (EpiVac AND OR SARS*)) OR \"mvc-cov1901\" OR mvccov1901*) OR ((sinopharm* AND OR OR CDX005*) OR ((calculator* OR algorithm* OR scale OR score OR scoring OR prediction* OR rule* ((predict* OR progno* OR decision*) AND model) (risk stratificat*)) AND (COVID* OR sars* OR post-covid*)) n-cov* OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR *cv-19* OR sars* OR sari OR \"severe acute respiratory \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" severity exacerbat* mild severe* severity* OR moderate* \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" ((subtype* OR polymorphism* OR mutant* OR variant* OR OR \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" OR (alpha AND OR OR (((variant OR VOC) AND (\"south africa\" OR southafrica* OR Nelson OR Mandela)) OR \"B.1.351\" OR B1351* OR 20H* OR 20C* OR 501Y* B1429* \"CAL.20C\" CAL20C*) (((variant OR VOC) AND (brazilian* OR Manaus* OR Amazon*)) OR \"P.1\" OR (gamma AND OR \"sars-cov2\" OR \"2019-ncov\" OR (wuhan* AND (virus OR viruses OR viral)) OR (covid* AND (virus OR viruses OR viral)) OR \"covid-19-related\" OR \"SARS-CoV-2-related\" OR \"SARS-CoV2-related\" OR \"2019-nCoV-related\" 024414\" \"CX024414\") (EpiVacCorona* \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR antisars* OR \"anti-sars-cov-2\" OR \"anti-sars-cov2\" OR \"anti-sarscov-2\" ((Oxford* AND OR Bio\") \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" \"n-cov\" OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR \"2019-ncov-related\" OR \"cv-19-related\" OR \"n-cov-related\" OR sars* OR sari OR acute syndrome\" antisars* \"anti-sars-cov-2\" ZIFIVAX* ) OR (((FINLAY* AND (covid* OR sars* OR \"sars-cov2\" OR \"2019-ncov\" OR (wuhan* AND (virus OR viruses OR viral)) OR (covid* AND (virus OR viruses OR viral)) OR \"covid-19-related\" OR \"SARS-CoV-2-related\" OR \"SARS-CoV2-related\" OR \"2019-nCoV-related\" OR \"cv-19-related\" n-cov* OR ncov* OR (wuhan* AND (virus OR viruses OR viral)) OR *cv-19* OR sars* OR sari OR \"severe acute respiratory OR (intubat* AND shield*)) OR ((protective* AND equipment*) OR dickersons* OR gumshoes* OR rubbers*) OR (mask OR masks) OR (facemask* OR OR OR OR ((head* AND cover*) OR gown*)) Connection with tools and projects Screening tool, data extraction forms, systematic review software, etc API and other technologies to connect with specic projects Connected with tools and projects 1 2 3 From a user perspective: Similar to traditional SR screening tools (e.g. Covidence, Rayyan) Articles are automatically uploaded based on pre-established strategies Search updated with the click of a button Information in the platform (reuse of data) can decrease the workload. AI and other technologies activated with the click of a button Information generated can contribute to the platform (optional) Screening tool Connected with tools and projects 1 2 3 Connected with tools and projects 1 2 3 Equity lter Connected with tools and projects 1 2 3 Based on PROGRESS-Plus (flexible) Similar approach (boolean + reuse of data + technology) Technology performs poorly Equity considerations Place of Residence Ethnicity Occupation Gender/Sex Religion Socio-economic status and Social capital Education Equity branch of L\u00b7OVE taxonomy D Connected with tools and projects 1 2 3 Connected with tools and projects 1 2 3 Example Filters Connected with tools and projects 1 2 3 Example\"Computers are incredibly fast, accurate, and stupid. Human beings are incredibly slow, inaccurate, and brilliant. Together they are powerful beyond imagination.\" Albert Einstein Thank you for your attention! Please contact us for further information and how to start working "}